The Jacob Shapiro Podcast

“The Longevity Dividend, or, Why You Shouldn’t Bathe in the Blood of Virgins”

Nov 17, 2025
Dylan Livingston, founder of the Alliance for Longevity Initiatives (A4LI), discusses the transformative potential of longevity science. He delves into how treating aging as a solvable issue could reshape economies, global power dynamics, and healthcare. The conversation covers the historical quest for immortality and how modern medicine aims to extend not just life, but healthy life. Livingston also shares insights on bipartisan policy advocacy, fundraising for research, and the economic impact of longer, healthier lives.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
ANECDOTE

Personal Path From Kid Fan To Founder

  • Dylan recounts seeing Aubrey de Grey at age 12, which seeded his long‑term interest in curing aging.
  • COVID and his grandfather's decline reignited his commitment and led to creating A4LI.
INSIGHT

Policy Gap Sparked A4LI's Creation

  • A4LI formed to fill a policy gap between longevity research and regulators.
  • The group quickly built a congressional caucus and pushed state-level Right‑to‑Try expansions.
ADVICE

Fund Aging Biology And Biomarkers Now

  • Increase federal funding specifically for aging biology research at NIA and support translational trials.
  • Prioritize biomarkers of aging to enable rigorous clinical trials and regulatory approval.
Get the Snipd Podcast app to discover more snips from this episode
Get the app